Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?

Edyta Maria Urbanska*, Jens Benn Sørensen, Eric Santoni-Rugiu

*Corresponding author af dette arbejde
OriginalsprogEngelsk
TidsskriftJournal of Thoracic Oncology
Vol/bind20
Udgave nummer6
Sider (fra-til)e71-e72
ISSN1556-0864
DOI
StatusUdgivet - jun. 2025

Citationsformater